STOCK TITAN

Onassis Holdings Retained Investment Bank Dalmore Group to Launch up to $75 Million Regulation A+ Offering (Mini IPO)

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
IPO

Onassis Holding Corp (OTC: ONSS) has announced its plans to launch a Regulation A+ offering to raise up to $75 million from the public. The biotech-focused holding company has partnered with Dalmore Group, a leading investment bank with over $2 billion in raised capital and more than 1 million processed transactions.

Dalmore Group, which has onboarded over 270 Reg A+ issuers since 2021, brings 16 years of experience and will provide strategic partnerships, marketing support, and secondary trading solutions for the offering.

Onassis Holding Corp (OTC: ONSS) ha annunciato i piani per lanciare una offerta RegA+ per raccogliere dal pubblico fino a 75 milioni di dollari. La holding biotech si è associata a Dalmore Group, una banca d'investimento leader con oltre 2 miliardi di dollari di capitale raccolto e oltre 1 milione di transazioni processate.

Dalmore Group, che dal 2021 ha onboardingato oltre 270 emittenti Reg A+, porta 16 anni di esperienza e offrirà partnership strategiche, supporto al marketing e soluzioni di trading secondario per l'offerta.

Onassis Holding Corp (OTC: ONSS) ha anunciado sus planes para lanzar una oferta Reg A+ para recaudar hasta 75 millones de dólares del público. La holding enfocada en biotecnología se ha asociado con Dalmore Group, un banco de inversión líder con más de 2 mil millones de dólares en capital captado y más de 1 millón de transacciones procesadas.

Dalmore Group, que ha incorporado a más de 270 emisores Reg A+ desde 2021, aporta 16 años de experiencia y brindará asociaciones estratégicas, apoyo de marketing y soluciones de negociación secundaria para la oferta.

Onassis Holding Corp (OTC: ONSS)가 공개 자금으로 최대 7500만 달러를 모으기 위한 Regulation A+ 공모를 시작할 계획이라고 발표했습니다. 생명공학에 중점을 둔 이 지주회사는 Dalmore Group와 협력 관계를 맺었으며, 이 은행은 모금 자본이 20억 달러를 초과하고 100만 건이 넘는 거래를 처리해 왔습니다.

Dalmore Group은 2021년 이후 270개 이상의 Reg A+ 발행사를 온보딩했으며, 16년의 경험을 바탕으로 이 공모에 대해 전략적 파트너십, 마케팅 지원 및 2차 거래 솔루션을 제공할 것입니다.

Onassis Holding Corp (OTC: ONSS) a annoncé ses plans pour lancer une offre Regulation A+ afin de lever jusqu'à 75 millions de dollars auprès du public. La société holding axée sur la biotechnologie s'est associée à Dalmore Group, une banque d'investissement de premier plan ayant mobilisé plus de 2 milliards de dollars de capitaux et ayant traité plus de 1 million de transactions.

Dalmore Group, qui a intégré plus de 270 émetteurs Reg A+ depuis 2021, apporte 16 ans d'expérience et fournira des partenariats stratégiques, un soutien marketing et des solutions de trading secondaire pour l'offre.

Onassis Holding Corp (OTC: ONSS) hat Pläne angekündigt, eine Regulation A+-Anzahlung zu starten, um von der Öffentlichkeit bis zu 75 Millionen Dollar zu beschaffen. Die auf Biotechnologie fokussierte Holding hat eine Partnerschaft mit Dalmore Group geschlossen, einer führenden Investmentbank mit über 2 Milliarden Dollar eingesammeltem Kapital und mehr als 1 Million verarbeiteten Transaktionen.

Dalmore Group, die seit 2021 mehr als 270 Reg A+-Emittenten an Bord geholt hat, bringt 16 Jahre Erfahrung mit und wird strategische Partnerschaften, Marketingunterstützung und Lösungen für den Sekundärhandel der Offering bereitstellen.

Onassis Holding Corp (OTC: ONSS) أعلنت عن خططها لطرح عرض Regulation A+ لجمع حتى 75 مليون دولار من الجمهور. الشركة القابضة التي تركز على علم الأحياء الدقيقة الحيوي (البيوتكنولوجي) قد تعاونت مع Dalmore Group، وهي بنك استثمار رائد يملك أكثر من 2 مليار دولار من رأس المال المُجمع وأكثر من مليون معاملة مُعالجة.

Dalmore Group، التي قامت بضم أكثر من 270 جهة إصدار Reg A+ منذ 2021، تقدم 16 عامًا من الخبرة وستوفر شراكات استراتيجية، دعمًا تسويقيًا وحلول تداول ثانوي لهذا العرض.

Onassis Holding Corp (OTC: ONSS) 已宣布计划推出一个Regulation A+发行,以向公众募集最多7500万美元。这家专注于生物技术的控股公司已与领先的投资银行Dalmore Group合作,该银行筹资资本超过20亿美元,并处理了超过100万笔交易

Dalmore Group自2021年以来已 onboard超过270家Reg A+发行人,拥有16年的经验,将为此次发行提供战略伙伴关系、市场营销支持和二级交易解决方案。

Positive
  • Partnership with established investment bank Dalmore Group, which has raised over $2B and processed 1M+ transactions
  • Access to strategic partnerships, marketing support, and secondary trading solutions through Dalmore
  • Potential to raise up to $75M annually through streamlined Reg A+ process
Negative
  • Potential dilution of existing shareholders through new share issuance
  • Uncertainty regarding the success of the capital raise

Onassis is about to launch a Reg D 506c to raise funds from US accredited investors

Dalmore Group's has more tha$2B raised by issuers and more than 1,000,000 processed

NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Onassis Holding Corp (OTC: ONSS), a biotech focused holding company, announced the launch of a Regulation A+ financing round. This follows an agreement with Dalmore Group.

Onassis Holdings Corp Logo

Reg A+ provides a streamlined process for companies to raise up to $75 million annually from the public. In aligning with Dalmore Group, Onassis looks to leverage the investment bank's prowess in capital raising through Regulations A+, CF, and D. Since 2021, Dalmore has on-boarded over 270 Reg A+ issuers, establishing itself as a leader in Reg A+ financing services.

With over 16 years of experience and deep relationships in multiple financial markets, Dalmore provides strategic partnerships with experts in marketing and PR, syndication partnerships with several Reg A+ marketplace platform distribution partners, and secondary trading solutions for their Reg A+ issuers.

About Onassis Holdings Corp Onassis Holdings Corp is a biotech holdings company, specializing in longevity and rejuvnation technologies by epigentics reprogramming.

Onassis holds A subsidiary called Ananda labs inc with its focus is to create a groundbreaking therapy based on patented proteins, that rejuvenate elderly cells, all while maintaining their distinct properties.

Forward-Looking Statements Statements that are not historical or current facts are "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause the Company's actual results to differ materially from historical or future results. "Believes," "should," "intends," "will," or "plans" are considered uncertain and forward-looking statements.

For more information about Onassis: 

Onassis Holdings Corp.
+1-516-620-6794
sales@onassis-holdings.com
www.ananda-labs.bio

Logo: https://mma.prnewswire.com/media/2069172/Onassis_Holdings_Corp_Logo.jpg

 

Cision View original content:https://www.prnewswire.com/news-releases/onassis-holdings-retained-investment-bank-dalmore-group-to-launch-up-to-75-million-regulation-a-offering-mini-ipo-302556111.html

SOURCE Onassis Holdings Corp

FAQ

What is the maximum amount ONSS can raise through its Regulation A+ offering?

Onassis Holdings (ONSS) can raise up to $75 million annually from the public through its Regulation A+ offering.

Who is Dalmore Group and what is their role in ONSS's offering?

Dalmore Group is an investment bank that will facilitate ONSS's Reg A+ offering. They have raised over $2B, processed over 1M transactions, and onboarded 270+ Reg A+ issuers since 2021.

What are the benefits of a Regulation A+ offering for ONSS?

A Regulation A+ offering provides ONSS with a streamlined process to raise capital from the public, along with access to marketing support, strategic partnerships, and secondary trading solutions through Dalmore Group.

How experienced is Dalmore Group in handling Regulation A+ offerings?

Dalmore Group has 16 years of experience in financial markets and has established itself as a leader in Reg A+ financing services, having onboarded over 270 Reg A+ issuers since 2021.

What type of company is Onassis Holdings (ONSS)?

Onassis Holdings (ONSS) is a biotech-focused holding company trading on the OTC markets.
Onassis Holdings Corp

OTC:ONSS

ONSS Rankings

ONSS Latest News

ONSS Stock Data

25.58k
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
New York